Applied DNA Sciences (NASDAQ:APDN) Now Covered by Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the technology company’s stock.

Separately, HC Wainwright lowered their price objective on shares of Applied DNA Sciences from $7.00 to $1.50 and set a “buy” rating for the company in a research note on Monday, June 10th.

Applied DNA Sciences Price Performance

Shares of NASDAQ APDN opened at $0.41 on Friday. Applied DNA Sciences has a 52-week low of $0.37 and a 52-week high of $37.20. The firm has a fifty day moving average of $2.06 and a 200-day moving average of $7.90. The stock has a market capitalization of $400,232.00, a PE ratio of -0.02 and a beta of 0.08.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.60) by ($0.71). Applied DNA Sciences had a negative net margin of 222.33% and a negative return on equity of 306.32%. The company had revenue of $0.93 million for the quarter, compared to analysts’ expectations of $0.90 million. Equities research analysts expect that Applied DNA Sciences will post -2.95 EPS for the current fiscal year.

Institutional Trading of Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC purchased a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences at the end of the most recent quarter. 22.22% of the stock is owned by hedge funds and other institutional investors.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.